Thymidine and Deoxyuridine Analytes (Plasma)




Test Mnemonic

PLTHY

CPT Codes

  • 82542 - QTY (1)

Includes

  • Thymidine
  • Deoxyuridine
  • Interpretation

Performing Laboratory

LabCorp


Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
1 mLPlasmaSodium heparin (Green) Frozen, ASAPSeparate plasma from cells ASAP and transfer to standard aliquot tube and freeze.

Alternate Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
1 mLPlasmaEDTA (Lavender) Frozen, ASAPSeparate plasma from cells ASAP and transfer to standard aliquot tube and freeze.
1 mLPlasmaACD A or B (Yellow) Frozen, ASAPSeparate plasma from cells ASAP and transfer to standard aliquot tube and freeze.

Minimum Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
0.5 mL     

Stability

Environmental Condition Description
AmbientAfter separation from cells: Unacceptable
RefrigeratedAfter separation from cells: 24 hours
FrozenAfter separation from cells: Indefinitely

Days Performed

Varies

Turnaround Time

11 - 15 days

Methodology

Name Description
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) 

Reference Range

Special Info

Thawed samples will be rejected.

Clinical Info

Plasma Thymidine/Deoxyuridine analyte is used for diagnosis of Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). MNGIE is an autosomal recessive disorder caused by mutations in the gene encoding thymidine phosphorylase (TP). The disease is characterized clinically by impaired eye movements, gastrointestinal dysmotility, cachexia, peripheral neuropathy, myopathy and leukoencephalopathy. Molecular genetic studies of MNGIE patients\tissues have revealed multiple deletions, depletion, and site-specific point mutations of mitochrondrial DNA. TP is a cytosolic enzyme required for nucleoside homeostatis. In MNGIE, TP activity is severely reduced and consequently levels of thymidine and deoxyuridine in plasma are dramatically elevated. MNGIE patients may benefit from hematopoietic stem cell transplantation.